Location: Home
  • search
  • go
  • Relate News
  • 5/26/2022China's First Decision In A Case Initiated Under Its Patent Linkage Sy...
  • 5/26/2022USTR Releases Special 301 Report On IP Protection With Special Section...
  • 5/26/2022April Licensing Trends Show Chinese Biotechs Expanding Beyond Oncology...
  • 5/26/2022Ten Trends of China's Pharmaceutical Industry in 2021 (PharmCube)
  • 5/26/2022Henlius and Abbott Enter Semi-Exclusive License Deal for Rituximab and...
  • 5/26/2022Data Snapshot: Top 20 Domestic Class 1 New Drugs by Sales in 2021
  • 5/26/2022Pharma Trading Platform Yaoshibang Applies for Hong Kong IPO
  • 5/25/2022CDE Issues the Technical Guidelines for Pharmaceutical Research and Ev...
  • 5/25/2022Hanmi Launches High-blood Pressure Drug Meiyaping (Amosartan) in China
  • 5/25/2022Beijing Health Chief Fired Following Investigation
  • 5/25/2022State Council Issues Notice on Major Tasks for Deepening Healthcare Re...
  • 5/25/2022Real-World Evidence Is Becoming a Pivotal Component in Chinese Healthc...
  • 5/24/2022New Draft Implementing Regulations Propose Key Changes for Pharmaceuti...
  • 5/24/2022Vir and WuXi Bio Terminate COVID Antibody Agreement
  • 5/24/2022ImaginAb and Yantai DongCheng Enter License Deal to Commercialize CD8...
  • 5/24/2022CASI and Tianshi Enter Sublicense Deal for Anti-Cd38 mAb CID-103 in Au...
  • 5/23/2022CDE Issues the Generic Format and Writing Guidelines for Package Inser...
  • 5/23/2022CDE Issues the Technical Guidelines for Clinical Evaluation of Intrave...
  • 5/23/2022Fujifilm Completes Construction of Bioprocessing Innovation & Collabor...
  • 5/23/2022Novartis's Promacta Approved in China for Expanded Use in Children Ag...
  • 5/23/2022Sinohealth: Chinese Hospital Drug Sales Fell 4% in Q1/2022
  • 5/23/2022IQVIA: Chinese Hospital Drug Market Rose 4.2% in Q1/2021
  • 5/23/2022VerImmune and Fosun Pharma Enter Licensing Deal for Virus-inspired Pa...
  • 5/23/2022Biopharma in China: The Emerging Global Force of Domestic Suppliers
  • 5/20/2022U.S., European Firms Rethink China Investment After Lockdowns
  • 5/20/2022VerImmune and Fosun in Deal for VerImmune's ViP Platform as Novel Im...
  • 5/20/2022Couple Plead Guilty to Smuggling and Fraud Charges After Sending ‘mRN...
  • 5/20/2022Recent Executive Moves
  • 5/20/2022Drug R&D and Product Registration News Digest May 2022 (3)
  • 5/19/2022Chinese Courts Handled Over 640,000 IPR Cases in 2021
  • Page:83/719 Total number of articles:21546: [First][<<] [81] [82] [83] [84] [85] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group